AI assistant
CRH PLC — Director's Dealing 2018
Nov 21, 2018
1980_dirs_2018-11-21_3ae7259c-24e7-4403-9f11-9dfc8377920e.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0805I
CRH PLC
21 November 2018
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Mary K. Rhinehart
2
Reason for the notification
a)
Position/status
Non-executive Director, CRH plc
b)
Initial Notification Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CRH plc
b)
LEI
549300MIDJNNTH068E74
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
American Depositary Receipts (ADRs) (each ADR represents 1 Ordinary Share of €0.32 each) [ISIN: IE0001827041]
b)
Nature of the transaction
Purchase of Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| US$27.34 | 1,000 |
d)
Aggregated information
- Aggregated volume
- Price
n/a
e)
Date of the transaction
20th November 2018
f)
Place of the transaction
New York
g)
Additional Information
n/a
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFEIFSFFASEEF